title: [Peridural morphine analgesia for the control of tumor-induced pain in gynecologic cancer patients].
abstract: 22 gynecological patients suffering from considerable tumor pain in an advanced carcinoma stage had a continuous peridural anaesthesia. 18 patients reported a very good and 4 patients a sufficient analgesia. The average morphine dose per day was 14 mg. The indwelling catheters remained on an average 27 days in site. Side effects, which could be related to the morphine PDA, occurred in one case.
mesh_terms: D002408:Catheters, Indwelling; D004305:Dose-Response Relationship, Drug; D005260:Female; D005833:Genital Neoplasms, Female / Q000503:physiopathology*; D006801:Humans; D007267:Injections; D009020:Morphine / Q000008:administration & dosage*; D010148:Intractable Pain / Q000188:drug therapy*; D010166:Palliative Care; D013116:Spinal Cord / Q000187:drug effects
chemical_list: D009020:Morphine
vernacular_title: Peridurale Morphin-Analgesie zur Bekämpfung von tumorbedingten Schmerzen bei gynäkologischen Karzinompatientinnen.